TABLE 3.
Multiple linear regression models assessing the association between baseline PCS‐C total scores and headache frequency and PedMIDAS scores at follow‐up.
| Variable | Beta | 95% Confidence interval (lower, upper) | Standard error | t‐Value | p_Value |
|---|---|---|---|---|---|
| Model 1: PedMIDAS at follow‐up as outcome variable (n = 119) | |||||
| PCS‐C baseline total | 0.81 | 0.13–1.48 | 0.33 | 2.36 | 0.020* |
| Sex (referent = male) | |||||
| Female | −1.26 | −17.88 to 15.34 | 8.38 | −0.15 | 0.880 |
| Gender diverse | −31.52 | −113.95 to 50.91 | 41.6 | −0.76 | 0.450 |
| Age | 0.81 | −2.14 to 3.75 | 1.48 | 0.54 | 0.588 |
| Baseline headache frequency | 0.35 | −0.53 to 1.24 | 0.44 | 0.80 | 0.427 |
| Baseline PedMIDAS | 0.29 | 0.14–0.44 | 0.08 | 3.84 | <0.001* |
| Taking preventative treatment (yes/no) | −6.45 | −24.63 to 11.74 | 9.18 | −0.70 | 0.484 |
| Model 2: Headache frequency at follow‐up as outcome variable (n = 119) | |||||
| PCS‐C baseline total | 0.04 | −0.10 to 0.19 | 0.074 | 0.56 | 0.575 |
| Sex (referent = male) | |||||
| Female | 1.41 | −2.17 to 4.99 | 1.81 | 0.78 | 0.437 |
| Gender diverse | −4.95 | −22.73 to 12.83 | 8.97 | −0.55 | 0.582 |
| Age | 0.23 | −0.41 to 0.86 | 0.32 | 0.71 | 0.479 |
| Baseline headache frequency | 0.57 | 0.38–0.76 | 0.10 | 5.95 | <0.001* |
| Baseline PedMIDAS score | 0.009 | −0.02 to 0.04 | 0.016 | 0.55 | 0.580 |
| Taking preventative treatment (yes/no) | 1.83 | −2.90 to 5.75 | 1.98 | 0.92 | 0.357 |
*
Indicates statistical significance at the p < 0.05 level.